GLUCOTRACK INC (GCTK:NASDAQ)
$1.03 -0.08 (-7.2072%)
Analysed GLUCOTRACK INC (GCTK:NASDAQ) News Sources
Glucotrack Announces $5.5 Million Financing
05-08-2026
yahoo.com
Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100
25-08-2026
yahoo.com
Glucotrack, Inc. Announces Reverse Stock Split
27-08-2026
yahoo.com
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business
02-09-2026
yahoo.com
Glucotrack Announces $11.5 Million Financing
11-09-2026
yahoo.com
Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform
23-09-2026
yahoo.com
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
24-09-2026
yahoo.com
Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™
25-09-2026
yahoo.com
Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14
30-09-2026
yahoo.com
Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn
01-10-2026
yahoo.com
What is the current price of GLUCOTRACK INC (GCTK:NASDAQ)?
The current price of GLUCOTRACK INC (GCTK:NASDAQ) is $1.03.
GLUCOTRACK INC (GCTK:NASDAQ) absolute price change since previous trading day?
The absolute price change of GLUCOTRACK INC (GCTK:NASDAQ) since the previous trading day is $-0.08.
GLUCOTRACK INC (GCTK:NASDAQ) percentage price change since previous trading day?
The percentage price change of GLUCOTRACK INC (GCTK:NASDAQ) since the previous trading day is -7.2072%.
What is the most recent average sentiment score for GLUCOTRACK INC (GCTK:NASDAQ)?
The most recent average sentiment score for GLUCOTRACK INC (GCTK:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for GLUCOTRACK INC (GCTK:NASDAQ)?
The most recent sentiment for GLUCOTRACK INC (GCTK:NASDAQ) is .
SEC-8K** Filing Available For GLUCOTRACK INC (GCTK:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.